Synaptogenix Invests $100M in Bittensor’s TAO, Signaling AI Crypto’s Rise Over Bitcoin
Synaptogenix, a biopharmaceutical company, has made a strategic pivot towards Bittensor’s AI-focused cryptocurrency TAO, signaling growing confidence in AI tokens over traditional digital assets like Bitcoin.
3 minutes to read








